People with Parkinson's disease who have a pacemaker-like device implanted in the brain spend an extra four-plus hours a day free of tremors and involuntary movements than they do on medication, ...
Case marks the beginning of a multi-site pivotal trial to evaluate Abbott’s system for management of treatment-resistant ...
Researchers from Carnegie Mellon University and Allegheny Health Network have developed a new method for deep brain stimulation. The technique, called “ DeepFocus ,” uses transnasal electrical ...
On Feb 24, the FDA approved Medtronic’s BrainSense Adaptive deep brain stimulation, a device that surgeons implant in patients’ chests with electrodes connecting to the brain. The system is ...
GlobalData on MSN5d
Abbott’s brain stimulation trial for depression kicks off at Mount SinaiNew York City’s Mount Sinai has become the first hospital in the US to perform a deep brain stimulation (DBS) implantation ...
Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the ...
The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...
Deep brain stimulation is most often offered to people with advanced Parkinson's disease who have unstable medication ...
The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of ...
A team of experts from the Icahn School of Medicine at Mount Sinai has become the first in the United States to perform a ...
Researchers from Carnegie Mellon University and Allegheny Health Network have developed a new method for deep brain stimulation. The technique, called “DeepFocus,” uses transnasal electrical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback